scispace - formally typeset
R

Richard Jove

Researcher at University of South Florida

Publications -  155
Citations -  27841

Richard Jove is an academic researcher from University of South Florida. The author has contributed to research in topics: Proto-oncogene tyrosine-protein kinase Src & STAT3. The author has an hindex of 77, co-authored 155 publications receiving 26422 citations.

Papers
More filters
Journal ArticleDOI

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

TL;DR: Well known for its role in tumour cell proliferation, survival, invasion and immunosuppression, JAK–STAT3 signalling also promotes cancer through inflammation, obesity, stem cells and the pre-metastatic niche.
Journal ArticleDOI

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

TL;DR: It is shown that VEGF expression correlates with Stat3 activity in diverse human cancer cell lines and indicates that Stat3 represents a common molecular target for blocking angiogenesis induced by multiple signaling pathways in human cancers.
Journal ArticleDOI

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.

TL;DR: It is proposed that tumor Stat-3 activity can mediate immune evasion by blocking both the production and sensing of inflammatory signals by multiple components of the immune system.
Journal Article

Activated STAT Signaling in Human Tumors Provides Novel Molecular Targets for Therapeutic Intervention

TL;DR: Inhibition of constitutively active STAT signaling pathways has been shown repeatedly to inhibit tumor cell growth in vitro and in vivo and provides a novel means for therapeutic intervention in human cancer.